Rescue of chemorefractory classical Hodgkin lymphoma with nivolumab and autologous stem-cell transplantation: Real-life experience

Hematol Oncol. 2021 Feb;39(1):134-136. doi: 10.1002/hon.2796. Epub 2020 Sep 11.

Authors

Valeria Buccheri^{1

2}, Giancarlo Fatobene^{1

3}, Fernanda M Santos², Rodrigo D Velasques², Marcelo Bellesso², Marcelo J Atanazio^{1

2}, Vanderson Rocha^{1

2

3}

Affiliations

¹ Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP) - Hematology Division, Sao Paulo, Brazil.
² Instituto do Cancer do Estado de São Paulo (ICESP) - Hematology Division, Sao Paulo, Brazil.
³ Hospital Sírio-Libanês (HSL) - Oncology Division, Sao Paulo, Brazil.

PMID: 32881003
DOI: 10.1002/hon.2796

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Adult
Female
Hematopoietic Stem Cell Transplantation*
Hodgkin Disease / therapy*
Humans
Male
Nivolumab / administration & dosage*
Transplantation, Autologous

Substances

Nivolumab